Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel

Anti-Cancer Drugs

Volumn 8, Issue 7, 1997, Pages 696-701

  Zhang, Xichen ^a   Burt, Helen M ^a,b   Mangold, Gina ^c   Dexter, Daniel ^c   Von Hoff, Daniel ^c   Mayer, Lawrence ^b,d   Hunter, William L ^a  

^a Angiotech Pharmaceuticals Inc   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CTRC Institute for Drug Development   (United States)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Biodistribution; In vivo efficacy; Micellar paclitaxel

Indexed keywords

COPOLYMER; CREMOPHOR; PACLITAXEL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LIVER; LUNG; LUNG CARCINOMA; MAXIMUM PERMISSIBLE DOSE; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; BODY WEIGHT; DRUG CARRIERS; HALF-LIFE; HUMANS; LUNG NEOPLASMS; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; MICELLES; PACLITAXEL; POLYESTERS; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030827821     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199708000-00008     Document Type: Article

References (21)

1. Spencer CM, Faulds D. Paclitaxel: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 1994; 48: 794-847.
2. Onetto N, Canett R, Winograd B, et al. Overview of paclitaxel safety. J Natl Cancer Inst Monogr 1993; 15: 131-9.
3. Dorr RT. Pharmacology and toxicology of Cremophor EL diluent. Ann Pharmacother 1994; 28: S11-4.
4. Goldspiel BR. Pharmaceutical issues: preparation, administration, stability and compatibility with other medications. Ann Pharmacother 1994; 28: S23-6.
5. Strubinger RM. Biopharmaceutics of paclitaxel (paclitaxel): formulation, activity, and pharmacokinetics. In: Suffness M, ed. Paclitaxel - science and applications. Boca Raton, FL: CRC Press, 1995: 237-58.
6. Sharma A, Straubinger RM. Novel paclitaxel formulations: preparation and characterisation of paclitaxel-containing liposomes. Pharmacol Res 1994; 11: 889-96.
7. Alkan-Onyuksel H, Ramakrishnan S, Chai HB, Pezzuto IM. A mixed micellar formulation suitable for the parenteral administration of paclitaxel. Pharmacol Res 1994; 11: 206-12.
8. Dordunoo SK, Burt HM. Solubility and stability of paclitaxel: effects of buffers and cyclodextrins. Int J Pharmac 1996; 133: 191-201.
9. Zhang X, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of paclitaxel. Int J Pharmac 1996; 132: 195-206.
10. 1 mice. Cancer Chemother Pharmacol 1994; 34: 465-71.
11. Innocenti F, Danesi R, Paolo AD, et al. Plasma and tissue disposition of paclitaxel (paclitaxel) after intraperitoneal administration in mice. Drug Metab Disp 1995; 23: 713-7.
12. Kataoka K, Kwon GS, Yokoyama M, Okano T, Sakurai Y. Block copolymer micells as vehicles for drug delivery. J Controlled Rel 1993; 24: 119-32.
13. Kwon GS, Kataoka K. Block polymer micelles as long-circulating drug vehicles. Adv Drug Del Rev 1995; 16: 295-309.
14. Kwon GS, Naito M, Kataoka K, Yokoyama M, Sakurai Y, Okano T. Block copolymer micelles as vehicles for hydrophobic drugs. Colloids Surfaces B: Biointerfaces 1994; 2: 429-34.
15. Kwon G, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J Controlled Rel 1994; 29: 17-23.
16. Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. Physical entrapment of adriamycin in AB block copolymer micelles. Pharmacol Res 1995; 12: 192-5.
17. Yokoyama M, Okano T, Sakurai Y, Kataoka K. Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Controlled Rel 1994; 32: 269-77.
18. Churchill JR, Hutchinson FG. Biodegradable amphiphilic copolymers. European Patent Application, 1986; no. 85304489.9.
19. Piskin E, Kaitian X, Denkbas EB, Kucukyavuz Z. Novel PDLLA/PEG copolymer micelles as drug carriers. J Biomater Sci Polym Ed 1995; 7: 359-73.
20. Hagan SA, Dunn SE, Garnett MC, Davies MC, Illum L, Davis SS. PLA-PEG micelles - a novel drug delivery system. Proc Int Symp Control Rel Bioact Mater 1995; 22: 194-5.
21. Hagen SA, Davis SS, Illum L, et al. Estimation of the poly(ethylene glycol) chain length of L-polyactide-polyethylene glycol in aqueous dispersions using viscoelastic measurements. Langmuir 1995; 11: 1482-5.